GLPwatch
Adlyxin vs Trulicity
Drug comparison
Last updated 2026-05-28 15:46 UTCAdlyxin (lixisenatide by Sanofi) and Trulicity (dulaglutide by Eli Lilly) are both injectable medications for type 2 diabetes, but Trulicity is also approved to reduce cardiovascular risk. Both are taken as once-weekly shots under the skin, though Adlyxin is a daily injection. The active ingredients differ: Adlyxin uses lixisenatide, while Trulicity uses dulaglutide.
AI summary of the sources below.
| Adlyxin | Trulicity | |
|---|---|---|
| Active ingredient | lixisenatide | dulaglutide |
| Manufacturer | sanofi | eli-lilly |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes | type 2 diabetes, cardiovascular risk reduction |
| Label updated | — | 2023-08-05 |